a p/e of 20 with EPS growth of 7% wouldn't suggest its cheap in comparison to the rest of the market. assuming that 7% is sustainable, a weaker macro environment and legislative changes to PHI/public hospitals are risks to maintaining or growing EPS. dividend growth is something the market doesn't appreciate atm with RHC, the trend is still down unfortunately, best to let the dust settle before buying?
Ramsay Health Care Fundamentals are Great, page-4
Add RHC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$42.78 |
Change
0.200(0.47%) |
Mkt cap ! $9.850B | |||
| Open | High | Low | Value | Volume |
| $43.10 | $43.30 | $42.70 | $31.58M | 735.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1757 | $42.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $42.87 | 2063 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| RHC (ASX) Chart |